CollPlant Biotechnologies (CLGN) Other Working Capital Changes (2019 - 2025)
CollPlant Biotechnologies (CLGN) posted Other Working Capital Changes of -$94000.0 for Q4 2025, up 27.69% on a QoQ basis from -$130000.0 in Q3 2025, and up 22.31% year-over-year from -$76851.4 in Q4 2024.
CollPlant Biotechnologies (CLGN) Other Working Capital Changes (2019 - 2025) Analysis & Trends
CollPlant Biotechnologies' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$94000.0 for Q4 2025.
- Quarterly Other Working Capital Changes rose 22.31% year-over-year to -$94000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$232000.0 (up 64.31% YoY) and the FY2025 annual result came in at -$336000.0, up 48.31% from the prior year.
- Other Working Capital Changes was -$94000.0 for Q4 2025 at CollPlant Biotechnologies, up from -$130000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $183000.0 in Q4 2024 and bottomed at -$175000.0 in Q4 2021.
- A 5-year average of $63461.5 and a median of $137000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes tumbled 945.24% — and 2025, when it surged 153.55%.
- CollPlant Biotechnologies' Other Working Capital Changes stood at -$337000.0 in 2021, then tumbled by 171.81% to -$916000.0 in 2022, then jumped by 103.38% to $31000.0 in 2023, then slumped by 490.32% to -$121000.0 in 2024, then climbed by 22.31% to -$94000.0 in 2025.
- Business Quant data shows CLGN's Other Working Capital Changes at -$94000.0 in Q4 2025, -$130000.0 in Q3 2025, and $113000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 170,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Dec 31, 2025 | 170,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Sep 30, 2025 | 171,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Sep 30, 2024 | 173,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Jun 30, 2024 | 158,000.00 |
| Mar 31, 2024 | 137,000.00 |
| Mar 31, 2024 | 137,000.00 |